These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8520513

  • 1. Prognostic factors in multiple myeloma.
    Kyle RA.
    Stem Cells; 1995 Aug; 13 Suppl 2():56-63. PubMed ID: 8520513
    [Abstract] [Full Text] [Related]

  • 2. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
    Scudla V, Kubalová D, Bacovský J, Lukes J, Vavrdová V.
    Cas Lek Cesk; 1996 Nov 20; 135(22):719-22. PubMed ID: 8998823
    [Abstract] [Full Text] [Related]

  • 3. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM.
    Cancer; 2003 May 15; 97(10):2440-52. PubMed ID: 12733143
    [Abstract] [Full Text] [Related]

  • 4. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma.
    Stasi R, Brunetti M, Parma A, Di Giulio C, Terzoli E, Pagano A.
    Cancer; 1998 May 15; 82(10):1860-6. PubMed ID: 9587117
    [Abstract] [Full Text] [Related]

  • 5. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
    Greipp PR, Lust JA, O'Fallon WM, Katzmann JA, Witzig TE, Kyle RA.
    Blood; 1993 Jun 15; 81(12):3382-7. PubMed ID: 8507875
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1655-8. PubMed ID: 17935664
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J.
    Ai Zheng; 2006 Apr 05; 25(4):461-4. PubMed ID: 16613681
    [Abstract] [Full Text] [Related]

  • 8. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep 05; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K, Pelliniemi TT, Rajamäki A, Tienhaara A, Laakso M, Lahtinen R.
    Br J Haematol; 1996 Feb 05; 92(2):370-4. PubMed ID: 8603002
    [Abstract] [Full Text] [Related]

  • 13. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan 05; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
    Kim SY, Min HJ, Park HK, Oh B, Kim TY, She CJ, Hwang SM, Kim M, Kim HK, Kim I, Yoon SS, Park S, Kim BK, Lee JH, Lee DS, Korea Multiple Myeloma Working Party.
    Biol Blood Marrow Transplant; 2011 Jun 05; 17(6):810-20. PubMed ID: 21220034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May 05; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 20. Effect of complete response on outcome following autologous stem cell transplantation for myeloma.
    Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Witzig TE, Lust JA, Larson D, Therneau TM, Kyle RA, Litzow MR, Greipp PR, Gertz MA.
    Bone Marrow Transplant; 2000 Nov 05; 26(9):979-83. PubMed ID: 11100277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.